Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis

Completed · Not applicable · Has a placebo group

Conditions studied: Cellulitis

In brief

Cellulitis is the medical term for an infection of the skin, with symptoms including redness, swelling, warmth, and pain. This group of symptoms is called inflammation, and is caused by the body's immune system responding to the infection. Standard care for cellulitis is using antibiotics to destroy the infection, but the inflammation can persist and cause a great deal of pain. The hypothesis of this study is that adding a single dose of an oral steroid (prednisone), which tempers the immune response, will reduce inflammation, reduce pain, and speed recovery. This hypothesis will be examined by recruiting a group of patients with cellulitis, and randomizing them to two sub-groups: one group will receive a dose of prednisone, while the other group will receive a placebo. Neither group will know what they received unless there is a problem. These subjects will be followed up at the 48 hour mark and the 7 day mark, and will have their results compared.

Key facts

Study ID

NCT01671423

Run by

Albert Einstein Healthcare Network

People needed

42

Starts

2012-08-01

Expected to finish

2015-09-01

Last updated by the study team

2021-02-10

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 to 70 years
• Current episode of cellulitis
• Erythema greater than 5 centimeters in any dimension
• Pain, swelling, warmth, and tenderness in the area without elevated borders
• Dispositioned for discharge from the Emergency Department or Observation
• Able to consent

You may not qualify if…

• Steroid use in the past 2 weeks
• History of adrenal insufficiency
• Any infection treated with antibiotics in the past 2 weeks
• Allergy to:
• Steroids
• Acetaminophen
• Trimethoprim-Sulphamethoxazole (TMP/SMX), Cephalexin, and Clindamycin (must be allergic to all three for exclusion)
• Oxycodone and Hydrocodone (must be allergic to both for exclusion)
• If subject is going to the Observation unit, allergy to:
• Clindamycin and Vancomycin (must be allergic to both for exclusion)
• Morphine and Hydromorphone (must be allergic to both for exclusion)
• Suspicion or presence of abscess
• Suspicion or presence of deep vein thrombosis
• Suspicion or presence of severe sepsis, as defined by:
• Sepsis
• Hypotension (systolic pressure < 90 mmHg or reduction of 40 mmHg from baseline)
• Failure of single end organ
• Suspicion or presence of septic shock, as defined by:
• Severe sepsis
• Hypotension that is refractory to fluid management
• Failure or more than one end organ
• Crepitus
• Change in mentation
• Tachycardia greater than 120 beats per minute
• Fever greater than or equal to 39 degrees Celsius

Where it is running

• Albert Einstein Medical Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.